Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.

Cochrane Methodology Quality assessment Quality improvement Risk of bias Systematic reviews

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
07 2020
Historique:
received: 08 08 2019
revised: 05 03 2020
accepted: 25 03 2020
pubmed: 5 4 2020
medline: 3 3 2021
entrez: 5 4 2020
Statut: ppublish

Résumé

To analyze how many non-Cochrane systematic reviews (NCSRs) used Cochrane's risk of bias (RoB) tool, domains they used, and whether judgments and comments about RoB were in line with Cochrane Handbook. This was a methodological (research-on-research) study. We retrieved NCSRs from PubMed, extracted information about methods used for RoB assessment, and if they used 2011 Cochrane RoB tool, we analyzed their RoB methods and compared them with Cochrane Handbook guidance. We included 508 NCSRs; 431 (85%) reported they analyzed RoB, and 269 (53%) used Cochrane RoB tool. Only 16 of those 269 (5.9%) reported both a judgment and a supporting comment in the Cochrane RoB table in the manuscript (N = 4) or in a supplementary file (N = 12). Fifteen reviews, with 158 included trials, used judgments low/high/unclear; 41% of analyzed available judgments were inadequate, either because judgment was not in line with comment or comment was missing. Most NCSRs use Cochrane RoB tool to assess RoB, but most of them reported it incompletely, with high prevalence of inadequate judgments. Authors, editors, and peer-reviewers should make an effort to improve completeness and adequacy of Cochrane RoB assessment in non-Cochrane reviews.

Identifiants

pubmed: 32247026
pii: S0895-4356(19)30720-6
doi: 10.1016/j.jclinepi.2020.03.019
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-119

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Livia Puljak (L)

Center for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Zagreb, Croatia. Electronic address: livia.puljak@unicath.hr.

Irma Ramic (I)

Department of Cardiac Anesthesia at Heart Center, Sarajevo, Bosnia and Herzegovina.

Coral Arriola Naharro (C)

University of Alcala Faculty of Medicine, Alcala de Henares, Spain.

Jana Brezova (J)

Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia.

Yi-Chen Lin (YC)

National Yang-Ming University, School of Medicine, Taipei, Taiwan.

Andrada-Alexandra Surdila (AA)

University of Laval School of Medicine, Quebec, Canada.

Ester Tomajkova (E)

Faculty of Medicine of Pavol Jozef Safarik University in Kosice, Kosice, Slovakia.

Inês Farias Medeiros (I)

Abel Salazar Institute for Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal.

Mishela Nikolovska (M)

Medical Faculty of Skopje, Ss Cyril and Methodius University, Skopje, North Macedonia.

Tina Poklepovic Pericic (T)

Cochrane Croatia, University of Split School of Medicine, Split, Croatia.

Ognjen Barcot (O)

Department of Surgery, University Hospital Split, Split, Croatia.

Maria Suarez Salvado (M)

University of Cadiz, School of Medicine, Cadiz, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH